114 related articles for article (PubMed ID: 7482581)
1. Effects of 3'-azido-3'-deoxythymidine on erythroid inducible gene expression in human K-562 leukemia cells.
Fowler DA; Weidner DA; Sommadossi JP
Toxicol Lett; 1995 Oct; 80(1-3):139-46. PubMed ID: 7482581
[TBL] [Abstract][Full Text] [Related]
2. Comparative effects of 3'-azido-3'-deoxythymidine and its metabolite 3'-amino-3'-deoxythymidine on hemoglobin synthesis in K-562 human leukemia cells.
Weidner DA; Bridges EG; Cretton EM; Sommadossi JP
Mol Pharmacol; 1992 Feb; 41(2):252-8. PubMed ID: 1538705
[TBL] [Abstract][Full Text] [Related]
3. A multifunctional 5-aminolevulinic acid derivative induces erythroid differentiation of K562 human erythroleukemic cells.
Berkovitch-Luria G; Yakobovitch S; Weitman M; Nudelman A; Rozic G; Rephaeli A; Malik Z
Eur J Pharm Sci; 2012 Aug; 47(1):206-14. PubMed ID: 22705251
[TBL] [Abstract][Full Text] [Related]
4. The role of the erythroid-specific delta-aminolevulinate synthase gene expression in erythroid heme synthesis.
Meguro K; Igarashi K; Yamamoto M; Fujita H; Sassa S
Blood; 1995 Aug; 86(3):940-8. PubMed ID: 7620186
[TBL] [Abstract][Full Text] [Related]
5. 3'-Azido-3'-deoxythymidine inhibits globin gene transcription in butyric acid-induced K-562 human leukemia cells.
Weidner DA; Sommadossi JP
Mol Pharmacol; 1990 Dec; 38(6):797-804. PubMed ID: 2174502
[TBL] [Abstract][Full Text] [Related]
6. 3'-Azido-3'-deoxythymidine inhibits erythroid-specific transcription factors in human erythroid K562 leukemia cells.
Bridges EG; Trentesaux C; Lahlil R; Spiga MG; Jeannesson P; Sommadossi JP
Eur J Haematol; 1996; 56(1-2):62-7. PubMed ID: 8599995
[TBL] [Abstract][Full Text] [Related]
7. Biphasic ordered induction of heme synthesis in differentiating murine erythroleukemia cells: role of erythroid 5-aminolevulinate synthase.
Lake-Bullock H; Dailey HA
Mol Cell Biol; 1993 Nov; 13(11):7122-32. PubMed ID: 8413301
[TBL] [Abstract][Full Text] [Related]
8. Impaired erythroid-specific gene expression in cAMP-dependent protein kinase-deficient murine erythroleukemia cells.
Pilz RB
J Biol Chem; 1993 Sep; 268(27):20252-8. PubMed ID: 8376386
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of beta-globin gene expression by 3'-azido-3'-deoxythymidine in human erythroid progenitor cells.
Spiga MG; Weidner DA; Trentesaux C; LeBoeuf RD; Sommadossi JP
Antiviral Res; 1999 Dec; 44(3):167-77. PubMed ID: 10651068
[TBL] [Abstract][Full Text] [Related]
10. Down-regulation of aminolevulinate synthase, the rate-limiting enzyme for heme biosynthesis in Alzheimer's disease.
Dwyer BE; Smith MA; Richardson SL; Perry G; Zhu X
Neurosci Lett; 2009 Aug; 460(2):180-4. PubMed ID: 19477221
[TBL] [Abstract][Full Text] [Related]
11. Increased expression of GATA-1 and NFE-2 erythroid-specific transcription factors during aclacinomycin-mediated differentiation of human erythroleukemic cells.
Trentesaux C; Nyoung MN; Aries A; Morceau F; Ronchi A; Ottolenghi S; Jardillier JC; Jeannesson P
Leukemia; 1993 Mar; 7(3):452-7. PubMed ID: 8445949
[TBL] [Abstract][Full Text] [Related]
12. Evidence for distinct regulation processes in the aclacinomycin- and doxorubicin-mediated differentiation of human erythroleukemic cells.
Morceau F; Aries A; Lahlil R; Devy L; Jardillier JC; Jeannesson P; Trentesaux C
Biochem Pharmacol; 1996 Mar; 51(6):839-45. PubMed ID: 8602880
[TBL] [Abstract][Full Text] [Related]
13. Regulation of beta-globin mRNA accumulation by heme in dimethyl sulfoxide (DMSO)-sensitive and DMSO-resistant murine erythroleukemia cells.
Fukuda Y; Fujita H; Garbaczewski L; Sassa S
Blood; 1994 Mar; 83(6):1662-7. PubMed ID: 8123858
[TBL] [Abstract][Full Text] [Related]
14. The centrality of PBGD expression levels on ALA-PDT efficacy.
Schauder A; Feuerstein T; Malik Z
Photochem Photobiol Sci; 2011 Aug; 10(8):1310-7. PubMed ID: 21655622
[TBL] [Abstract][Full Text] [Related]
15. Changes in DNA methylation of erythroid-specific genes in K562 cells exposed to phenol and hydroquinone.
Li Y; Wu XR; Li XF; Suriguga ; Yu CH; Li YR; Yi ZC
Toxicology; 2013 Oct; 312():108-14. PubMed ID: 23973255
[TBL] [Abstract][Full Text] [Related]
16. Effect of 5-aminolevulinic acid on erythropoiesis: a preclinical in vitro characterization for the treatment of congenital sideroblastic anemia.
Fujiwara T; Okamoto K; Niikuni R; Takahashi K; Okitsu Y; Fukuhara N; Onishi Y; Ishizawa K; Ichinohasama R; Nakamura Y; Nakajima M; Tanaka T; Harigae H
Biochem Biophys Res Commun; 2014 Nov; 454(1):102-8. PubMed ID: 25450364
[TBL] [Abstract][Full Text] [Related]
17. Differential induction responses of delta-aminolevulinate synthase mRNAs during erythroid differentiation: use of nonradioactive in situ hybridization.
Mitani K; Fujita H; Hayashi N; Yamamoto M; Sassa S
Am J Hematol; 1992 Jan; 39(1):63-4. PubMed ID: 1536142
[TBL] [Abstract][Full Text] [Related]
18. Deficient heme and globin synthesis in embryonic stem cells lacking the erythroid-specific delta-aminolevulinate synthase gene.
Harigae H; Suwabe N; Weinstock PH; Nagai M; Fujita H; Yamamoto M; Sassa S
Blood; 1998 Feb; 91(3):798-805. PubMed ID: 9446639
[TBL] [Abstract][Full Text] [Related]
19. Erythroleukemia differentiation. Distinctive responses of the erythroid-specific and the nonspecific delta-aminolevulinate synthase mRNA.
Fujita H; Yamamoto M; Yamagami T; Hayashi N; Sassa S
J Biol Chem; 1991 Sep; 266(26):17494-502. PubMed ID: 1894633
[TBL] [Abstract][Full Text] [Related]
20. Regulation of erythroid 5-aminolevulinate synthase expression during erythropoiesis.
Sadlon TJ; Dell'Oso T; Surinya KH; May BK
Int J Biochem Cell Biol; 1999 Oct; 31(10):1153-67. PubMed ID: 10582344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
